Search All
MIN
Search by Name
Search by Ticker
ALC
Alcidion Group Ltd
Health Care Technology
·
Healthcare
Turn on notifications
About Alcidion Group Ltd
Commentary
SOURCE
ACTION
FUND MANAGER
DATE
Cyan Investment Management continues to hold their investment because Alcidion Group Ltd is among a number of the fund's holdings aggressively pursuing new material contracts, with the manager holding high expectations that some of these will land in the coming weeks and months. No specific financial results or contract details were disclosed for Alcidion Group beyond this general expectation, with the share price noted at approximately $0.11 at the time of commentary.
Monthly Report
30 Jun 2026
.
Cyan Investment Management
No Change
Monthly Report
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Alcidion Group Ltd (ASX:ALC)
Frequently asked questions
Who is investing in Alcidion Group Ltd (ASX:ALC)?
Fund managers including Cyan Investment Management, Salter Brothers, Elston Asset Management and Tamim Funds Management have invested in Alcidion Group Ltd (ASX:ALC).
What is the short interest in Alcidion Group Ltd (ASX:ALC)?
According to ASIC filings, there is negligible or no short interest in Alcidion Group Ltd (ASX:ALC).
What does Alcidion Group Ltd (ASX:ALC) do?
Alcidion Group Limited (ALC) develops and licenses healthcare software, including the Miya Precision platform and its modules: Miya Observations, Flow, Task Management, and PAS. The company resells partner healthcare software and provides implementation, support, maintenance, systems integration, and data analysis services. Alcidion serves healthcare customers across Australia, New Zealand, and the United Kingdom.